FORGE Coalition Wins $47.3M Federal Award
The Tampa Bay-area coalition will use the funding to build radiopharmaceutical manufacturing and life sciences training infrastructure.
Updated on Nov. 7, 2026 in Cancer

Live Poll
Should local governments use public money to fund cancer research and biotech companies?
The FORGE coalition received a $47.3 million award from the U.S. Economic Development Administration. The funding will support five major initiatives centered on radiopharmaceutical production and life sciences workforce development in the Tampa Bay region.
Why it matters
Radiopharmaceuticals are used in cancer diagnosis and treatment, and the project aims to build local capacity for producing them. The initiatives also target workforce training and support for early-stage biotech companies in Florida.
The federal award totals $47.3 million, funding a 130,000-square-foot radiopharmaceutical facility and a four-story, 120,000-square-foot office and lab. The FORGE Incubator will support up to 20 early-stage companies, though the source does not detail the budget split among the five initiatives.
The players
Moffitt Cancer Center
Moffitt Cancer Center is a Tampa-based comprehensive cancer center and research institution affiliated with the University of South Florida.
University of South Florida
The University of South Florida is a public research university based in Tampa, Florida.
Pasco-Hernando State College
Pasco-Hernando State College is a public college serving Pasco and Hernando counties in Florida.
The details
Moffitt Cancer Center will build a radiopharmaceutical manufacturing facility at the Speros campus in Pasco County. The Integrated Theranostics Center will let scientists produce isotopes and develop therapies for research and clinical trials, while the University of South Florida and Pasco-Hernando State College will expand training programs.
Timeline
March: Organizations applied for the federal award.
Q1 or Q2 2028: The FORGE Incubator is expected to open.
Late 2029: The radiopharmaceutical manufacturing facility is expected to be completed.
Big Picture
Radiopharmaceutical therapies, which deliver radiation directly to cancer cells, have grown into a major area of oncology treatment. This FORGE project seeks to expand Florida's capacity to manufacture these isotope-based therapies locally rather than relying on distant production.
Patients in Florida may eventually have access to locally produced radiopharmaceutical treatments as the manufacturing facility comes online. The timeline extends to late 2029, so near-term treatment options are not directly affected by this award.
The takeaway
Expanding domestic radiopharmaceutical production could shorten supply chains for cancer isotopes. Readers following cancer care in Florida should watch for facility milestones as the project moves toward its planned openings.
Further reading
For more on related treatment research, explore Cancer coverage on Wisevoter.
Source note: This article includes information reported by St Pete Catalyst.
Live Poll
Should local governments use public money to fund cancer research and biotech companies?










